Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation?
MacKinnon
S
S
Department of Haematology, Chenies Mews,University College London Hospitals, London WCE1 HX6, UK. s.mackinnon@ucl.ac.uk
D001782:Blood Donors; D001804:Blood Transfusion, Autologous; D006086:Graft vs Host Disease / Q000628:therapy; D020544:Graft vs Leukemia Effect; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D007951:Leukemia, Myeloid / Q000628:therapy; D017708:Leukocyte Transfusion; D008223:Lymphoma / Q000628:therapy; D009101:Multiple Myeloma / Q000628:therapy; D018579:Patient Selection; D012074:Remission Induction; D014184:Transplantation, Homologous